Josef Flammer
Swiss ophthalmologist and researcher
Josef Flammer is a renowned Swiss ophthalmologist and researcher, known for his significant contributions to the field of glaucoma research. His work has greatly influenced the understanding and management of this eye condition, which is a leading cause of blindness worldwide.
Early Life and Education[edit | edit source]
Josef Flammer was born in Switzerland, where he developed an early interest in medicine and the sciences. He pursued his medical degree at the University of Basel, one of the oldest universities in Switzerland, known for its strong emphasis on research and innovation.
Career[edit | edit source]
After completing his medical studies, Flammer specialized in ophthalmology, focusing on the study and treatment of glaucoma. He became a professor at the University of Basel, where he dedicated his career to both teaching and research.
Research Contributions[edit | edit source]
Flammer is best known for his pioneering research on the vascular aspects of glaucoma. He introduced the concept of "Flammer Syndrome," a condition characterized by a predisposition to vascular dysregulation, which can affect blood flow to the optic nerve and contribute to the development of glaucoma.
His research has led to a better understanding of the pathophysiology of glaucoma, emphasizing the importance of blood flow and vascular health in the management of the disease. This has opened new avenues for treatment, focusing not only on intraocular pressure but also on improving ocular blood flow.
Publications and Influence[edit | edit source]
Flammer has published numerous articles in peer-reviewed journals, contributing significantly to the body of knowledge in ophthalmology. His work is widely cited by other researchers and has influenced clinical practices worldwide.
Awards and Recognition[edit | edit source]
Throughout his career, Josef Flammer has received numerous awards and honors for his contributions to medical science and ophthalmology. His work has been recognized by various professional organizations, and he is considered a leading figure in his field.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
